Effect of Shirodhara on mental disease after Covid

A randomized controlled study to assess the effect of â??Shirodharaâ?? as an add-on therapy on the post Covid common mental disorders (Depression and Anxiety) in Covid-19 survivors.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043444

Enrollment

Registered

2022-06-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Aged between 18 to 60 years 2.Having developed COVID positive status 3.Diagnosed as having major depressive and generalized anxiety disorder by a psychiatrist (co-supervisor) as per diagnostic criteria listed in DSM-5 4. Currently receiving treatment (Fluoxetine and or Clonazepam) and planning to pursue follow up psychiatry care for next 1 month at study center. 5.Able to understand Hindi/English 6.Medically stable to participate in Shirdohara intervention as assessed by treating psychiatrist on medical examination.

Exclusion criteria

Exclusion criteria: 1.Past history of psychiatric illness prior to developing COVID . 2.Reporting presence of suicidal thoughts/ideation or attempts within last 2 weeks. 3.Already on any alternative form of therapy besides standard pharmacotherapy and or psychotherapy for depression 4.Having history suggestive of being diagnosed any medical condition requiring hospitalization currently or in recent past 6 weeks making participation in Shirodhara based program difficult 5.The patient having symptoms like cough, sneezing, running nose currently making participation in Shirodhara based program difficult 6.Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
1.Evaluate the efficacy of Shirodhara on mental health disorders 2.Assessment of effect of Shirodhara on selected biomarkers viz. Sr. Cortisol, Lipid profile, CRP, Timepoint: Day 1 Day 8 Day 15 and Day 30	—

Secondary

Measure	Time frame
1.Assessment of the quality of lifeTimepoint: Day 1 Day 8 Day 15 and Day 30	—

Countries

India

Contacts

Public ContactDr Manoj Shamkuwar

All India Institute of Ayurveda

dr.ananthramsharma@gmail.com9423039441

Outcome results